Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on Cellebrite DI (CLBT – Research Report) today. The company’s shares closed last Friday at $11.39.
Van Rhee covers the Technology sector, focusing on stocks such as Cellebrite DI, Asure, and Rimini Street. According to TipRanks, Van Rhee has an average return of 12.3% and a 53.08% success rate on recommended stocks.
Currently, the analyst consensus on Cellebrite DI is a Strong Buy with an average price target of $12.40, which is an 8.87% upside from current levels. In a report released on February 16, Bank of America Securities also upgraded the stock to a Buy with a $12.00 price target.
See the top stocks recommended by analysts >>
CLBT market cap is currently $2.25B and has a P/E ratio of -26.28.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cellebrite DI (CLBT) Company Description:
Cellebrite offers digital intelligence solutions. Its platform and solutions help law enforcement agencies (police departments, armed services, public defenders, start departments) and enterprise customers to better collect, review, analyze, and manage digital data in legally sanctioned investigations.
Read More on CLBT:
